{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Bromebric_Acid",
  "nciThesaurus": {
    "casRegistry": "5711-40-0",
    "chebiId": "",
    "chemicalFormula": "C11H9BrO4",
    "definition": "A derivative of bromoacrylic acid with cytostatic and antineoplastic activity. Bromebric acid appears to inhibit purine synthesis, oxidative phosphorylation and DNA synthesis. This agent inhibits tumor cell growth and causes cell cycle arrest. This agent may also have some use in the phrophylaxis of migraine.",
    "fdaUniiCode": "FGE8818GWA",
    "identifier": "C72089",
    "preferredName": "Bromebric Acid",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C272"
    ],
    "synonyms": [
      "(E)-3-p-Anisoyl-3-bromoacrylic Acid",
      "BROMEBRIC ACID",
      "Bromebric Acid"
    ]
  }
}